Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Wearable Cardioverter Defibrillator in Tachycardia Induced Cardiomyopathy. A Prospective Study

NCT03388905 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT03388905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03388905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Wearable Cardioverter Defibrillator in Tachycardia Induced Cardiomyopathy. A Prospective Study
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2018
Completion date
December 31, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tachycardia-induced cardiomyopathy